Palatin Technologies, Inc. To Report Fiscal Year 2012 Third Quarter Results; Teleconference and Webcast to be held on May 14, 2012
CRANBURY, N.J., May 8, 2012 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) will announce its third quarter, fiscal year 2012 financial results on Monday, May 14, 2012 before the open of the U.S. financial markets.
Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on May 14, 2012, which will include discussion of the results of operations in greater detail and an update on corporate developments.
|
Schedule for the Financial Results Press Release, Conference Call / Webcast | ||
|
- |
Q3 Fiscal Year 2012 Financial Results Press Release |
5/14/2012 at 7:30 a.m. ET |
|
- |
Q3 Fiscal Year 2012 Conference Call-Live |
5/14/2012 at 11:00 a.m. ET |
|
Domestic Dial-In Number |
1-888-264-8945 | |
|
International Dial-In Number |
1-913-312-0724 | |
|
Passcode |
8113465 | |
|
- |
Q3 Fiscal Year 2012 Conference Call-Replay |
5/14-5/21/2012 |
|
Domestic Dial-In Number |
1-888-203-1112 | |
|
International Dial-In Number |
1-719-457-0820 | |
|
Passcode |
8113465 | |
|
- |
Webcast Live and Replay Access |
|
|
The webcast and replay can be accessed by logging on to the "Investor/Media Center-Webcasts" section of Palatin's website at http://www.palatin.com | ||
About Palatin Technologies, Inc.
Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at www.palatin.com.
SOURCE Palatin Technologies, Inc.
RELATED LINKS
http://www.palatin.com
More by this Source
Palatin Technologies Announces Third Quarter Fiscal Year 2013 Results and Update on Development of Bremelanotide for Female Sexual Dysfunction
May 14, 2013, 07:30 ET
Palatin Technologies, Inc. To Report Fiscal Year 2013 Third Quarter Results; Teleconference and Webcast to be held on May 14, 2013
May 08, 2013, 07:30 ET
Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-Specific Peptides for Sexual Dysfunction
May 02, 2013, 07:30 ET
Featured Video
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.
- Site Preview
-
Close Site Preview
-
View FullScreen
